ArticleBritish journal of cancer2013

VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide.

P Orlandi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.